Sign up to save your podcasts
Or
Share Key Considerations of Gene Therapy Development: A Caregiver's Story
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Key Considerations of Gene Therapy Development: A Caregiver's Story
Emily Walsh Martin, PhD, spoke with Amber Freed, founder and CEO of SLC6A1 Connect, a patient organization focused on accelerating the development of therapies for SLC6A1 patients like her son Maxwell.
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
View all episodes
By American Society of Gene & Cell Therapy
4.9
1616 ratings
Emily Walsh Martin, PhD, spoke with Amber Freed, founder and CEO of SLC6A1 Connect, a patient organization focused on accelerating the development of therapies for SLC6A1 patients like her son Maxwell.
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
More shows like ASGCT Podcast Network
View all
Radiolab
43,837 Listeners
Planet Money
30,609 Listeners
Hidden Brain
43,687 Listeners
The NPR Politics Podcast
26,012 Listeners
Nature Podcast
756 Listeners
HBR IdeaCast
154 Listeners
Science Magazine Podcast
818 Listeners
Science Friday
6,467 Listeners
The Daily
113,121 Listeners
Up First from NPR
56,944 Listeners
The Readout Loud
337 Listeners
Throughline
16,512 Listeners
Consider This from NPR
6,462 Listeners
The Ezra Klein Show
16,525 Listeners
Cell & Gene: The Podcast
38 Listeners